Oncocyte: Medical Advisory Board
Oncocyte said it has formed a new medical advisory board to advise the company on the development and clinical advancement of its portfolio of tests, including its immuno-oncology and blood-based monitoring tests.
Chairing the MAB is David Gandara, professor of medicine emeritus at the UC Davis School of Medicine. Gandara is a recognized authority in biomarker research and drug development in oncology, with extensive experience in translational research in lung cancer. Other board members include Daniel Hayes, professor at the University of Michigan Rogel Cancer Center; Fred Hirsch, executive director at the Center of Thoracic Oncology in the Tisch Cancer Institute at Mount Sinai and professor of medicine at the Icahn School of Medicine; Heinz-Josef Lenz, co-leader of the gastrointestinal cancers program at the USC Norris Comprehensive Cancer Center; and Ignacio Wistuba, chair of the department of translational molecular pathology at The University of Texas MD Anderson Cancer Center.